Quitting smoking: Licensed medications are effective

May 30, 2013

Nicotine replacement therapy and other licensed drugs can help people quit smoking, according to a new systematic review published in The Cochrane Library. The study, which is an overview of previous Cochrane reviews, supports the use of the smoking cessation medications that are already widely licensed internationally, and shows that another drug licensed in Russia could hold potential as an effective and affordable treatment.

In Europe and the US the only medications currently licensed for are nicotine replacement therapies (NRTs) such as nicotine patches and gums, the antidepressant and the drug varenicline, which blunts the effects of nicotine on receptors in the brain. In Russia and other parts of Eastern Europe cytisine, which is similar to varenicline, is also licensed for smoking cessation.

The authors combined the findings of existing Cochrane reviews on the subject, using all the available data from across the individual reviews. In total, they collected evidence from 267 studies, which together involved a total of 101,804 people. The studies covered a wide variety of licensed and unlicensed smoking cessation medications, comparing the treatments with placebo, and the three main treatments with each other. If a person stopped smoking for six months or longer, this was considered a successful quit attempt.

The three widely licensed medications and cytisine all improved smokers' chances of quitting. The odds of quitting were about 80% higher with single NRTor bupropion than with placebo, and between two and three times higher with varenicline than with placebo. However, Varenicline was about 50% more effective than any single formulation of NRT (patches, gum, sprays, lozenges and inhalers), but similar in efficacy to combining two types of NRT. Based on two recent trials, cytisine improved the chances of quitting nearly four-fold compared with placebo. Among other treatments tested, , another , was more effective than placebo but did not offer any additional improvement when combined with NRT.

"This review provides strong evidence that the three main treatments, , bupropion and varenicline, can all help people to stop smoking," said lead researcher Kate Cahill of the Department of Primary Care Health Sciences at the University of Oxford in Oxford, UK. "Although cytisine is not currently licensed for smoking cessation in most of the world, these data suggest it has potential as an effective and affordable therapy."

The researchers also assessed the safety of different medications. Bupropion, which is known to trigger occasional seizures in vulnerable people, did not lead to an increase in the rate of seizures when used for smoking cessation in its slow-release version. Overall, NRT, bupropion and varenicline are considered low risk treatments, although the researchers say the results are currently less clear-cut for varenicline.

"Further research may be warranted into the safety of ," said Cahill. "However, in the trials we looked at we did not detect evidence of any increase in neuropsychiatric, heart or circulatory problems."

Explore further: Nicotine replacement therapies may not be effective in helping people quit smoking, study says

More information: Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.:CD009329.DOI: 10.1002/14651858.CD009329.pub2

Related Stories

Many options available to help smokers kick the habit

October 16, 2012

Smokers who have tried to quit and failed may be tempted to just give up, particularly if they hear statistics like the fact that most quit attempts will be unsuccessful. But smokers today have many options to help them quit, ...

Light smokers benefit from nicotine-replacement medications

April 11, 2013

(Medical Xpress)—Light daily smokers, those who smoke fewer than 10 cigarettes per day, have greater success quitting when provided stop-smoking medications and assisted by counselors. Those are the key conclusions of research ...

Recommended for you

Young adults found displaying symptoms of net addiction

October 17, 2014

In 2012, Allen Frances, MD, professor emeritus and former chair of the department of psychiatry at Duke University, cautioned that "Internet Addiction" could be the next new fad diagnosis, complete with "an exuberant trumpeting ...

Can 'love hormone' oxytocin protect against addiction?

March 19, 2014

(Medical Xpress)—Researchers at the University of Adelaide say addictive behaviour such as drug and alcohol abuse could be associated with poor development of the so-called "love hormone" system in our bodies during early ...

Nicotine vaccine prevents nicotine from reaching the brain

May 2, 2012

If smoking a cigarette no longer delivers pleasure, will smokers quit? It's the idea behind a nicotine vaccine being created by MIT and Harvard researchers, in which an injection of synthetic nanoparticles prompts the immune ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.